Cargando…

Altered sodium channel function in dystrophin/utrophin-deficient cardiomyocytes

Detalles Bibliográficos
Autores principales:	Koenig, Xaver, Mike, Agnes, Mille, Markus, Cervenka, René, Lukács, Péter, Nagl, Katrin, Dang, Xuan Bach, Todt, Hannes, Bittner, Reginald E, Hilber, Karlheinz
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016535/ http://dx.doi.org/10.1186/1471-2210-10-S1-A25

Ejemplares similares

Ion channel impairments in dystrophic cardiomyocytes
por: König, Xaver, et al.
Publicado: (2009)

Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart
por: Koenig, Xaver, et al.
Publicado: (2011)

Calcium current properties in dystrophin‐deficient ventricular cardiomyocytes from aged mdx mice
por: Rubi, Lena, et al.
Publicado: (2018)

Decreased inward rectifier potassium current I(K1) in dystrophin-deficient ventricular cardiomyocytes
por: Rubi, Lena, et al.
Publicado: (2016)

New structural determinants of charged local anaesthetic block of voltage-gated sodium channels
por: Lukács, Péter, et al.
Publicado: (2012)

Impaired L-type Ca(2+) channel function in the dystrophic heart
por: Koenig, Xaver, et al.
Publicado: (2012)

Differential modulation of rNa(V)1.4 channel inactivated states by lidocaine and its charged analogue QX222
por: Lukács, Péter, et al.
Publicado: (2011)

A molecular switch between the outer and the inner vestibules of the voltage-gated Na(+) channel
por: Cervenka, René, et al.
Publicado: (2010)

The permanently charged lidocaine analogue QX222 acts as a blocker from the intracellular side and as an inactivation modulator from the extracellular side in a mutant Na(V)1.4 channel
por: Lukács, Péter, et al.
Publicado: (2010)

Second-hit kinetic perturbations reveal structural features of the domain IV S6 segment associated with fast inactivation
por: Cervenka, René, et al.
Publicado: (2008)

The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac arrhythmias
por: Kovar, Michael, et al.
Publicado: (2011)

A conformational change of the domain IV S6 segment of the voltage-gated sodium channel during inactivation
por: Gawali, Vaibhavkumar S, et al.
Publicado: (2012)

A Molecular Switch between the Outer and the Inner Vestibules of the Voltage-gated Na(+) Channel
por: Zarrabi, Touran, et al.
Publicado: (2010)

From frog oocytes to mammalian cells: substantial differences in modulation of Na(V)1.4 channel slow kinetic behaviour by the β1 subunit
por: Lukács, Péter, et al.
Publicado: (2009)

Double mutant gating perturbation analysis predicts a high conformational stability of the domain IV S6 segment of the voltage-gated Na(+ )channel
por: Cervenka, René, et al.
Publicado: (2009)

Voltage-Dependent Sarcolemmal Ion Channel Abnormalities in the Dystrophin-Deficient Heart
por: Koenig, Xaver, et al.
Publicado: (2018)

Efforts to induce cardiac electrophysiological properties in skeletal myoblasts in vitro
por: Koenig, Xaver, et al.
Publicado: (2008)

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
por: Koenig, Xaver, et al.
Publicado: (2012)

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile()
por: Koenig, Xaver, et al.
Publicado: (2013)

Distinct modulation of inactivation by a residue in the pore domain of voltage-gated Na(+) channels: mechanistic insights from recent crystal structures
por: Cervenka, Rene, et al.
Publicado: (2018)

Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel–Mediated Cardiotoxicity
por: Hackl, Benjamin, et al.
Publicado: (2021)

Evidence for a Physiological Role of T-Type Ca Channels in Ventricular Cardiomyocytes of Adult Mice
por: Marksteiner, Jessica, et al.
Publicado: (2022)

Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
por: Sonnemann, Kevin J., et al.
Publicado: (2009)

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
por: Chen, Hung-Chih, et al.
Publicado: (2017)

The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels
por: Hackl, Benjamin, et al.
Publicado: (2022)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Rubi, Lena, et al.
Publicado: (2016)

The Crystal Structures of Dystrophin and Utrophin Spectrin Repeats: Implications for Domain Boundaries
por: Muthu, Muralidharan, et al.
Publicado: (2012)

The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation
por: Koenig, Xaver, et al.
Publicado: (2015)

Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice
por: Li, Dejia, et al.
Publicado: (2010)

Phosphorylation alters the mechanical stiffness of a model fragment of the dystrophin homologue utrophin
por: Ramirez, Maria Paz, et al.
Publicado: (2022)

Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Ca(v)1.2 channel modulation under basal conditions
por: Ebner, Janine, et al.
Publicado: (2019)

Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies
por: Perronnet, Caroline, et al.
Publicado: (2010)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
por: Hanson, Britt, et al.
Publicado: (2022)

Erratum of “Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies”
por: Perronnet, Caroline, et al.
Publicado: (2010)

Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
por: Ham, Daniel J., et al.
Publicado: (2019)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
por: Hardee, Justin P., et al.
Publicado: (2020)

Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy
por: Pant, Meghna, et al.
Publicado: (2015)

Phasic Store-Operated Ca(2+) Entry During Excitation-Contraction Coupling in Skeletal Muscle Fibers From Exercised Mice
por: Lilliu, Elena, et al.
Publicado: (2020)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin‐deficient mice and Duchenne muscular dystrophy
por: Perkins, Kelly J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q9jconprvq4i96af5p1m5d424m